CN103520572B - 一种用于治疗特应性皮炎的中药组合物及其制备方法 - Google Patents
一种用于治疗特应性皮炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103520572B CN103520572B CN201310491169.7A CN201310491169A CN103520572B CN 103520572 B CN103520572 B CN 103520572B CN 201310491169 A CN201310491169 A CN 201310491169A CN 103520572 B CN103520572 B CN 103520572B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- heat
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 112
- 201000008937 atopic dermatitis Diseases 0.000 title claims abstract description 42
- 206010012438 Dermatitis atopic Diseases 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims description 22
- 241000628997 Flos Species 0.000 claims abstract description 26
- 241001649190 Campsis Species 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 22
- 239000009636 Huang Qi Substances 0.000 claims abstract description 20
- 210000000582 Semen Anatomy 0.000 claims abstract description 16
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 15
- 241001407408 Berberis fortunei Species 0.000 claims abstract description 11
- 241000012040 Dickinsia hydrocotyloides Species 0.000 claims abstract description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 229940079593 drugs Drugs 0.000 claims description 32
- 238000010438 heat treatment Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 13
- 229940040145 Liniment Drugs 0.000 claims description 12
- 239000000865 liniment Substances 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 7
- 235000011837 pasties Nutrition 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 230000002829 reduced Effects 0.000 claims description 4
- 229940099259 Vaseline Drugs 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 230000000051 modifying Effects 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 72
- 238000004519 manufacturing process Methods 0.000 abstract description 18
- 231100000331 toxic Toxicity 0.000 abstract description 9
- 230000035876 healing Effects 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 4
- 231100000486 side effect Toxicity 0.000 abstract description 4
- 238000001647 drug administration Methods 0.000 abstract description 3
- 239000002547 new drug Substances 0.000 abstract description 3
- 210000004369 Blood Anatomy 0.000 description 125
- 239000008280 blood Substances 0.000 description 125
- 208000003251 Pruritus Diseases 0.000 description 80
- 210000003491 Skin Anatomy 0.000 description 79
- 201000010099 disease Diseases 0.000 description 56
- 208000002193 Pain Diseases 0.000 description 52
- 230000036407 pain Effects 0.000 description 51
- 210000000952 Spleen Anatomy 0.000 description 45
- 206010011224 Cough Diseases 0.000 description 38
- 230000001737 promoting Effects 0.000 description 37
- 230000001717 pathogenic Effects 0.000 description 35
- 210000004072 Lung Anatomy 0.000 description 32
- 210000003734 Kidney Anatomy 0.000 description 31
- 201000004624 dermatitis Diseases 0.000 description 28
- 210000002784 Stomach Anatomy 0.000 description 27
- 241000411851 herbal medicine Species 0.000 description 26
- 208000001848 Dysentery Diseases 0.000 description 25
- 239000000243 solution Substances 0.000 description 24
- 208000005679 Eczema Diseases 0.000 description 23
- 210000004185 Liver Anatomy 0.000 description 23
- 206010012735 Diarrhoea Diseases 0.000 description 22
- 206010007247 Carbuncle Diseases 0.000 description 21
- 210000000214 Mouth Anatomy 0.000 description 21
- 206010037660 Pyrexia Diseases 0.000 description 21
- 231100001003 eczema Toxicity 0.000 description 21
- 208000006820 Arthralgia Diseases 0.000 description 19
- 210000001124 Body Fluids Anatomy 0.000 description 19
- 210000003205 Muscles Anatomy 0.000 description 19
- 239000010839 body fluid Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 206010040882 Skin lesion Diseases 0.000 description 18
- 206010042674 Swelling Diseases 0.000 description 18
- 231100000444 skin lesion Toxicity 0.000 description 18
- 230000002522 swelling Effects 0.000 description 18
- 230000035922 thirst Effects 0.000 description 18
- 231100000614 Poison Toxicity 0.000 description 17
- 230000017531 blood circulation Effects 0.000 description 17
- 230000001684 chronic Effects 0.000 description 17
- 244000052769 pathogens Species 0.000 description 17
- 206010030113 Oedema Diseases 0.000 description 15
- 206010016286 Febrile disease Diseases 0.000 description 14
- 206010001928 Amenorrhoea Diseases 0.000 description 13
- 206010019233 Headache Diseases 0.000 description 13
- 210000002216 Heart Anatomy 0.000 description 13
- 206010047700 Vomiting Diseases 0.000 description 13
- 201000000736 amenorrhea Diseases 0.000 description 13
- 231100000540 amenorrhea Toxicity 0.000 description 13
- 231100000869 headache Toxicity 0.000 description 13
- 230000001105 regulatory Effects 0.000 description 13
- 206010027514 Metrorrhagia Diseases 0.000 description 12
- 206010063409 Acarodermatitis Diseases 0.000 description 11
- 210000000481 Breast Anatomy 0.000 description 11
- 206010010774 Constipation Diseases 0.000 description 11
- 206010013990 Dysuria Diseases 0.000 description 11
- 210000000936 Intestines Anatomy 0.000 description 11
- 208000005687 Scabies Diseases 0.000 description 11
- 241000447727 Scabies Species 0.000 description 11
- 206010040872 Skin infection Diseases 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- 230000007958 sleep Effects 0.000 description 11
- 208000006673 Asthma Diseases 0.000 description 10
- 210000002683 Foot Anatomy 0.000 description 10
- 206010018836 Haematochezia Diseases 0.000 description 10
- 210000004915 Pus Anatomy 0.000 description 10
- 206010072736 Rheumatic disease Diseases 0.000 description 10
- 230000001154 acute Effects 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 210000001015 Abdomen Anatomy 0.000 description 9
- 206010010356 Congenital anomaly Diseases 0.000 description 9
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 9
- 208000005171 Dysmenorrhea Diseases 0.000 description 9
- 206010013935 Dysmenorrhoea Diseases 0.000 description 9
- 210000003414 Extremities Anatomy 0.000 description 9
- 206010017553 Furuncle Diseases 0.000 description 9
- 229940112824 Paste Drugs 0.000 description 9
- 206010040943 Skin ulcer Diseases 0.000 description 9
- 210000002435 Tendons Anatomy 0.000 description 9
- 201000008286 diarrhea Diseases 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 231100000019 skin ulcer Toxicity 0.000 description 9
- 208000001780 Epistaxis Diseases 0.000 description 8
- 206010060891 General symptom Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 206010022437 Insomnia Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 208000001431 Psychomotor Agitation Diseases 0.000 description 8
- 206010038743 Restlessness Diseases 0.000 description 8
- 230000002950 deficient Effects 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 230000002147 killing Effects 0.000 description 8
- 210000000056 organs Anatomy 0.000 description 8
- 244000045947 parasites Species 0.000 description 8
- 230000025627 positive regulation of urine volume Effects 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 201000010874 syndrome Diseases 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 206010000087 Abdominal pain upper Diseases 0.000 description 7
- 206010003549 Asthenia Diseases 0.000 description 7
- 208000002173 Dizziness Diseases 0.000 description 7
- 206010023126 Jaundice Diseases 0.000 description 7
- 206010027327 Menstrual disease Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000004087 circulation Effects 0.000 description 7
- 230000003203 everyday Effects 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 235000008216 herbs Nutrition 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 230000003902 lesions Effects 0.000 description 7
- 239000002398 materia medica Substances 0.000 description 7
- 238000010791 quenching Methods 0.000 description 7
- 230000000552 rheumatic Effects 0.000 description 7
- 230000001225 therapeutic Effects 0.000 description 7
- 208000002894 Beriberi Diseases 0.000 description 6
- 210000000988 Bone and Bones Anatomy 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 6
- 206010013954 Dysphoria Diseases 0.000 description 6
- 206010014198 Eczema infantile Diseases 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 6
- 206010043458 Thirst Diseases 0.000 description 6
- 241000223238 Trichophyton Species 0.000 description 6
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial Effects 0.000 description 6
- 231100000406 dermatitis Toxicity 0.000 description 6
- 201000009910 diseases by infectious agent Diseases 0.000 description 6
- 230000003419 expectorant Effects 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000004438 eyesight Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000003211 malignant Effects 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000003014 reinforcing Effects 0.000 description 6
- 230000002040 relaxant effect Effects 0.000 description 6
- 230000002269 spontaneous Effects 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010010726 Conjunctival oedema Diseases 0.000 description 5
- 206010010741 Conjunctivitis Diseases 0.000 description 5
- 208000006111 Contracture Diseases 0.000 description 5
- 206010018987 Haemorrhage Diseases 0.000 description 5
- 206010022000 Influenza Diseases 0.000 description 5
- 206010022114 Injury Diseases 0.000 description 5
- 206010062575 Muscle contracture Diseases 0.000 description 5
- 206010029410 Night sweats Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 206010033799 Paralysis Diseases 0.000 description 5
- 210000003800 Pharynx Anatomy 0.000 description 5
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 5
- 210000003932 Urinary Bladder Anatomy 0.000 description 5
- 230000003213 activating Effects 0.000 description 5
- 230000003110 anti-inflammatory Effects 0.000 description 5
- 230000001166 anti-perspirant Effects 0.000 description 5
- 239000003213 antiperspirant Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 238000007599 discharging Methods 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 230000036565 night sweats Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000036961 partial Effects 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 201000005404 rubella Diseases 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 230000002588 toxic Effects 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 206010000496 Acne Diseases 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 4
- 206010012435 Dermatitis and eczema Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 210000003128 Head Anatomy 0.000 description 4
- 210000003026 Hypopharynx Anatomy 0.000 description 4
- 208000009856 Lung Disease Diseases 0.000 description 4
- 206010025421 Macule Diseases 0.000 description 4
- 206010025482 Malaise Diseases 0.000 description 4
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 4
- 208000008425 Protein Deficiency Diseases 0.000 description 4
- 208000008128 Pulmonary Tuberculosis Diseases 0.000 description 4
- 206010039085 Rhinitis allergic Diseases 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 208000002474 Tinea Diseases 0.000 description 4
- 206010068760 Ulcers Diseases 0.000 description 4
- 206010048222 Xerosis Diseases 0.000 description 4
- 201000010105 allergic rhinitis Diseases 0.000 description 4
- 230000001139 anti-pruritic Effects 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 239000003908 antipruritic agent Substances 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 230000003115 biocidal Effects 0.000 description 4
- 201000002393 blood protein disease Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000001605 fetal Effects 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000000292 leukogenic Effects 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 229930014456 matrine Natural products 0.000 description 4
- 210000004914 menses Anatomy 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 230000000116 mitigating Effects 0.000 description 4
- 101710031899 moon Proteins 0.000 description 4
- 230000003000 nontoxic Effects 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 230000001047 pyretic Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- -1 sublimed preparation Substances 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 231100001002 xerosis Toxicity 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010003402 Arthropod sting Diseases 0.000 description 3
- 206010052737 Atopic disease Diseases 0.000 description 3
- 210000004204 Blood Vessels Anatomy 0.000 description 3
- 206010061590 Blood disease Diseases 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- 206010013023 Diphtheria Diseases 0.000 description 3
- 206010013781 Dry mouth Diseases 0.000 description 3
- 206010015037 Epilepsy Diseases 0.000 description 3
- LPLVUJXQOOQHMX-MYOOOWEVSA-N Glycyrrhizic acid Natural products O=C(O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](C(=O)O)O2)[C@@H](O[C@@H]2C(C)(C)[C@H]3[C@@](C)([C@H]4C(=O)C=C5[C@](C)([C@]4(C)CC3)CC[C@]3(C)[C@H]5C[C@](C(=O)O)(C)CC3)CC2)O1 LPLVUJXQOOQHMX-MYOOOWEVSA-N 0.000 description 3
- 206010018830 Haematemesis Diseases 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 210000003141 Lower Extremity Anatomy 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 206010037714 Quadriplegia Diseases 0.000 description 3
- 206010037844 Rash Diseases 0.000 description 3
- 210000003802 Sputum Anatomy 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 229940076185 Staphylococcus aureus Drugs 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 229960001967 Tacrolimus Drugs 0.000 description 3
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 3
- 231100000765 Toxin Toxicity 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 230000001058 adult Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000000740 bleeding Effects 0.000 description 3
- 231100000319 bleeding Toxicity 0.000 description 3
- 230000001914 calming Effects 0.000 description 3
- 201000009030 carcinoma Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000003628 erosive Effects 0.000 description 3
- 235000019525 fullness Nutrition 0.000 description 3
- 230000002068 genetic Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 201000002138 hematopoietic system disease Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000000968 intestinal Effects 0.000 description 3
- 201000002364 leukopenia Diseases 0.000 description 3
- 231100001022 leukopenia Toxicity 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 201000005505 measles Diseases 0.000 description 3
- 230000001617 migratory Effects 0.000 description 3
- 230000001473 noxious Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000002335 preservative Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002035 prolonged Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000000171 quenching Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000000306 recurrent Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000002048 spasmolytic Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 229920000638 styrene acrylonitrile Polymers 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000002936 tranquilizing Effects 0.000 description 3
- 206010002383 Angina pectoris Diseases 0.000 description 2
- 210000003423 Ankle Anatomy 0.000 description 2
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 2
- 210000001367 Arteries Anatomy 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 210000004556 Brain Anatomy 0.000 description 2
- 206010006451 Bronchitis Diseases 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 210000001736 Capillaries Anatomy 0.000 description 2
- 229940113118 Carrageenan Drugs 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 210000004351 Coronary Vessels Anatomy 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 229960004397 Cyclophosphamide Drugs 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 210000000232 Gallbladder Anatomy 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 210000004247 Hand Anatomy 0.000 description 2
- 208000002287 Hemorrhoids Diseases 0.000 description 2
- 210000001624 Hip Anatomy 0.000 description 2
- 208000006572 Human Influenza Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 210000001503 Joints Anatomy 0.000 description 2
- 241000731961 Juncaceae Species 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 208000004396 Mastitis Diseases 0.000 description 2
- 244000007703 Mentha citrata Species 0.000 description 2
- 235000007421 Mentha citrata Nutrition 0.000 description 2
- 235000008660 Mentha x piperita subsp citrata Nutrition 0.000 description 2
- 229940105902 Mint extract Drugs 0.000 description 2
- 206010028334 Muscle spasms Diseases 0.000 description 2
- 208000003067 Myocardial Ischemia Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 235000019082 Osmanthus Nutrition 0.000 description 2
- 241000333181 Osmanthus Species 0.000 description 2
- XVPBINOPNYFXID-LHDUFFHYSA-N Oxymatrine Chemical compound C([C@@H]1CCC[N+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-LHDUFFHYSA-N 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000006641 Skin Disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 210000004243 Sweat Anatomy 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 210000001113 Umbilicus Anatomy 0.000 description 2
- 210000002700 Urine Anatomy 0.000 description 2
- 210000003462 Veins Anatomy 0.000 description 2
- 206010052769 Vertigos Diseases 0.000 description 2
- 210000003905 Vulva Anatomy 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000003187 abdominal Effects 0.000 description 2
- 201000004484 acute conjunctivitis Diseases 0.000 description 2
- 231100000293 acute skin toxicity Toxicity 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229930013930 alkaloids Natural products 0.000 description 2
- 201000009961 allergic asthma Diseases 0.000 description 2
- 230000000954 anitussive Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000000259 anti-tumor Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 229910052803 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000916 dilatatory Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 201000000297 erysipelas Diseases 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000032686 female pregnancy Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229960000785 fluocinonide Drugs 0.000 description 2
- 230000002496 gastric Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 235000005035 ginseng Nutrition 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000002949 hemolytic Effects 0.000 description 2
- 230000002607 hemopoietic Effects 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002757 inflammatory Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000749 insecticidal Effects 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- 229930015582 oxymatrine Natural products 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000000607 poisoning Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 201000004700 rosacea Diseases 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 210000004215 spores Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000001131 transforming Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002918 waste heat Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18β-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 206010000210 Abortion Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000269 Abscess Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000009763 Acute rheumatism Diseases 0.000 description 1
- 206010002156 Anal fistula Diseases 0.000 description 1
- 208000007502 Anemia Diseases 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- 206010003119 Arrhythmia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 240000003917 Bambusa tulda Species 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 1
- 208000002352 Blister Diseases 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 229940046731 Calcineurin inhibitors Drugs 0.000 description 1
- 240000000218 Cannabis sativa Species 0.000 description 1
- 206010007521 Cardiac arrhythmias Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 230000036536 Cave Effects 0.000 description 1
- 210000003756 Cervix Mucus Anatomy 0.000 description 1
- 210000003467 Cheek Anatomy 0.000 description 1
- 208000007287 Cheilitis Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 210000004252 Chorionic Villi Anatomy 0.000 description 1
- 241000253343 Chromadorea Species 0.000 description 1
- 208000007451 Chronic Bronchitis Diseases 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 208000001590 Congenital Abnormality Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 208000004981 Coronary Disease Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000338702 Cupido minimus Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 210000004443 Dendritic Cells Anatomy 0.000 description 1
- 208000002925 Dental Caries Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 208000000718 Duodenal Ulcer Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229940095399 Enema Drugs 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Ethacridine lactate Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- AEUTYOVWOVBAKS-UWVGGRQHSA-N Ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 1
- 208000004526 Exfoliative Dermatitis Diseases 0.000 description 1
- 210000000744 Eyelids Anatomy 0.000 description 1
- 210000003754 Fetus Anatomy 0.000 description 1
- 210000001061 Forehead Anatomy 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 208000001130 Gallstone Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 210000004392 Genitalia Anatomy 0.000 description 1
- 229940097043 Glucuronic Acid Drugs 0.000 description 1
- 229940073144 Glycyrrhetinic acid Drugs 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000001786 Gonorrhea Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000006750 Hematuria Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000005252 Hepatitis A Diseases 0.000 description 1
- 206010019780 Hepatitis infectious Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 206010062060 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010020937 Hypoaesthesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010021198 Ichthyosis Diseases 0.000 description 1
- 206010021197 Ichthyosis Diseases 0.000 description 1
- 210000004969 Inflammatory Cells Anatomy 0.000 description 1
- 206010022017 Inguinal hernias Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 210000000867 Larynx Anatomy 0.000 description 1
- 206010024738 Lobar pneumonia Diseases 0.000 description 1
- 206010024855 Loss of consciousness Diseases 0.000 description 1
- 210000004705 Lumbosacral Region Anatomy 0.000 description 1
- 210000002751 Lymph Anatomy 0.000 description 1
- 210000002050 Maxilla Anatomy 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L Mercury(I) chloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N Monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 210000002464 Muscle, Smooth, Vascular Anatomy 0.000 description 1
- UIAGMCDKSXEBJQ-UHFFFAOYSA-N Nimodipine Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-UHFFFAOYSA-N 0.000 description 1
- 229960000715 Nimodipine Drugs 0.000 description 1
- 210000001331 Nose Anatomy 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 210000004681 Ovum Anatomy 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 210000003516 Pericardium Anatomy 0.000 description 1
- 206010062515 Periorbital contusion Diseases 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010062080 Pigmentation disease Diseases 0.000 description 1
- 229940023488 Pill Drugs 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 210000001369 Pituitary-Adrenal System Anatomy 0.000 description 1
- 210000002826 Placenta Anatomy 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N Potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 241000669298 Pseudaulacaspis pentagona Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- 206010037868 Rash maculo-papular Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 101710044433 SAG Proteins 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 229940031000 Streptococcus pneumoniae Drugs 0.000 description 1
- 231100000617 Superantigen Toxicity 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010042772 Syncope Diseases 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 210000001138 Tears Anatomy 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000015450 Tilia cordata Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044008 Tonsillitis Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046736 Urticarias Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046901 Vaginal discharge Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 231100000611 Venom Toxicity 0.000 description 1
- 210000001048 Venoms Anatomy 0.000 description 1
- 208000001756 Virus Disease Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008549 Vitex agnus castus Species 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 210000000707 Wrist Anatomy 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 229940052228 Zinc Oxide Paste Drugs 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000000274 adsorptive Effects 0.000 description 1
- 230000000172 allergic Effects 0.000 description 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 description 1
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical compound [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000003042 antagnostic Effects 0.000 description 1
- 230000000507 anthelmentic Effects 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001458 anti-acid Effects 0.000 description 1
- 230000003266 anti-allergic Effects 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000002429 anti-coagulation Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000002924 anti-infective Effects 0.000 description 1
- 230000001754 anti-pyretic Effects 0.000 description 1
- 230000000941 anti-staphylcoccal Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 201000001320 atherosclerosis Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000005549 barrier dysfunction Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000000711 cancerogenic Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000002612 cardiopulmonary Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 201000004559 cerebral degeneration Diseases 0.000 description 1
- 239000005482 chemotactic factor Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000008739 coronary artery disease Diseases 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000002354 daily Effects 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960004189 ethacridine lactate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 201000005569 gout Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000002440 hepatic Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002218 hypoglycaemic Effects 0.000 description 1
- 230000001146 hypoxic Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved Effects 0.000 description 1
- 200000000018 inflammatory disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000000366 juvenile Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000004301 light adaptation Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 230000001338 necrotic Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing Effects 0.000 description 1
- 201000008125 pain agnosia Diseases 0.000 description 1
- 230000003119 painkilling Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002093 peripheral Effects 0.000 description 1
- 230000003285 pharmacodynamic Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000003389 potentiating Effects 0.000 description 1
- 230000003449 preventive Effects 0.000 description 1
- 201000002367 primary immunodeficiency disease Diseases 0.000 description 1
- 230000000750 progressive Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000004625 regulation of water loss via skin Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000022 skin irritation / corrosion Toxicity 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000002142 suicide Effects 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000004450 types of analysis Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000021228 wine soup Nutrition 0.000 description 1
- 239000009792 yinqiao Substances 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical compound [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N β-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310491169.7A CN103520572B (zh) | 2013-10-18 | 2013-10-18 | 一种用于治疗特应性皮炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310491169.7A CN103520572B (zh) | 2013-10-18 | 2013-10-18 | 一种用于治疗特应性皮炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103520572A CN103520572A (zh) | 2014-01-22 |
CN103520572B true CN103520572B (zh) | 2015-12-23 |
Family
ID=49923159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310491169.7A Expired - Fee Related CN103520572B (zh) | 2013-10-18 | 2013-10-18 | 一种用于治疗特应性皮炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103520572B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103976905B (zh) * | 2014-05-29 | 2016-05-11 | 上海清轩生物科技有限公司 | 一种具有消炎抗过敏作用的植物提取液混合物 |
CN104055956A (zh) * | 2014-07-08 | 2014-09-24 | 马丽 | 一种治疗皮肤瘙痒症的中药组合物 |
FR3046541B1 (fr) * | 2016-01-12 | 2018-02-09 | Societe Industrielle Limousine D'application Biologique | Principe actif obtenu a partir d'ophiopogon japonicus pour le traitement de la dermatite atopique |
CN105661664B (zh) * | 2016-01-25 | 2017-08-01 | 邱定武 | 一种治疗痛风的袜底及其制备草药 |
CN106038813A (zh) * | 2016-06-10 | 2016-10-26 | 周振勇 | 一种治疗玫瑰糠疹的药物 |
KR101782268B1 (ko) * | 2016-09-01 | 2017-09-28 | 경희대학교 산학협력단 | 생약 혼합 추출물을 포함하는 아토피 피부염의 치료용 조성물 |
CN107582799A (zh) * | 2017-10-27 | 2018-01-16 | 成都中医药大学附属医院 | 一种治疗特应性皮炎的药物组合物及其制备方法和用途 |
CN108434242A (zh) * | 2018-06-22 | 2018-08-24 | 中南民族大学 | 一种用于治疗糖尿病及其并发症的药物组合物、制备方法及其用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1129577A (zh) * | 1995-09-15 | 1996-08-28 | 贾阳春 | 普癣丸(块) |
CN1214261A (zh) * | 1998-10-21 | 1999-04-21 | 余际康 | 一种治疗皮肤病的口服药 |
CN102416127A (zh) * | 2011-12-09 | 2012-04-18 | 崔国志 | 一种治疗牛皮癣的中药散剂 |
-
2013
- 2013-10-18 CN CN201310491169.7A patent/CN103520572B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1129577A (zh) * | 1995-09-15 | 1996-08-28 | 贾阳春 | 普癣丸(块) |
CN1214261A (zh) * | 1998-10-21 | 1999-04-21 | 余际康 | 一种治疗皮肤病的口服药 |
CN102416127A (zh) * | 2011-12-09 | 2012-04-18 | 崔国志 | 一种治疗牛皮癣的中药散剂 |
Also Published As
Publication number | Publication date |
---|---|
CN103520572A (zh) | 2014-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN102145064B (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN102205107B (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
CN102755596B (zh) | 一种治疗痰湿型乳腺增生的中药及制备方法 | |
CN102000164A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN104815037A (zh) | 一种治疗风湿蕴毒型慢性湿疹的药物及其制备方法 | |
CN103041262B (zh) | 一种治疗慢性前列腺炎的中药灌肠剂及其制备方法 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN104069474A (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
CN103933405A (zh) | 用于治疗气血两虚型烧伤的药物组合物及其制备方法 | |
CN103495072B (zh) | 一种治疗支气管扩张病的中药组合物及其制备方法 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN104906430A (zh) | 一种治疗干眼症的中药制剂及其制备方法 | |
CN104815232A (zh) | 一种治疗原发性肺动脉高压的中药制剂及其制备方法 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN104857121A (zh) | 一种治疗高血脂症的药物组合物及其应用 | |
CN104257871B (zh) | 用于治疗湿热毒蕴型急性网状淋巴管炎的药物组合物及其制备方法 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN103028028B (zh) | 一种治疗原发性肝癌的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhou Bopeng Inventor before: Li Dianchang Inventor before: Liang Diecong |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151118 Address after: 262409 Shandong city of Weifang province Changle County resident town government Tang a surname Applicant after: Li Tianchang Address before: Shinan District 266073 Shandong city of Qingdao province No. 7 Yinchuan West Road, Yinhai No. 1 7-2-505 Applicant before: Li Dianchang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151223 Termination date: 20161018 |
|
CF01 | Termination of patent right due to non-payment of annual fee |